Clinical Evaluation of LightSheer Duet 805nm HS Handpiece
- Conditions
- Hair Removal
- Interventions
- Device: LightSheer Duet HS handpiece
- Registration Number
- NCT01801202
- Lead Sponsor
- Lumenis Be Ltd.
- Brief Summary
* The study will re-confirm that the LightSheer Duet HS 805 nm handpiece is safe for removal of unwanted hair, and will result in hair removal and permanent hair count reduction.
* Twenty (20)subjects, Fitzpatrick Skin Type I-IV will be included in a single site.
* Each subject will receive five treatments at four to six week intervals and return for follow-up visits at three and six months after the last treatment for evaluation of the treated areas.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 21
- Able to read, understand and provide written Informed Consent;
- Healthy adult, male or female, 18 years of age or older with skin type I-IV;
- Having a suitable treatment area for hair removal;
- Able and willing to comply with the treatment/follow-up schedule and requirements;
- Women of child-bearing potential (women who have not had a hysterectomy, bilateral oophorectomy or are not postmenopausal) are required to be using a reliable method of birth control at least three months prior to enrollment and throughout the course of the study.
- Pregnant, expectation of pregnancy, postpartum or nursing (<6 months);
- Hormonal disorders that may affect hair growth;
- Immunosuppressive diseases, including AIDS and HIV infection, or use of immunosuppressive medications;
- Livedo reticularis;
- Uncontrolled systemic diseases such as diabetes;
- Active infections in the treated area;
- Dysplastic nevi;
- Significant concurrent skin conditions or any inflammatory skin conditions;
- Active cold sores, open lacerations or abrasions;
- Chronic or cutaneous viral, fungal, or bacterial diseases;
- Current cancer;
- History of skin cancer or pre-cancerous lesions at the treatment areas;
- Use of Accutaneâ„¢ (Isotretinoin) within the past six month;
- Keloid formation in the treatment area;
- Tattoos in the treatment area;
- Bleeding coagulopathies or use of anticoagulants;
- Auto-immune disorders;
- Erythema ab igne, when identified treatments should be discontinued;
- Photosensitivity disorder that can be exacerbated by laser or intense light;
- Herpes simplex in the treatment area;
- Use of medications, herbal supplements, perfumes or cosmetics that may affect sensitivity to light;
- Poor wound healing;
- Sunburns;
- Unable or unlikely to refrain from artificial tanning, including the use of tanning booths, prior (at least a week) and during the course of the evaluation;
- Prior skin treatment with laser or other devices on the same treated areas within the last six months prior to study enrollment or during the course of the study.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Hair removal LightSheer Duet HS handpiece hair removal treatment using 805nm LightSheer Duet HS handpiece
- Primary Outcome Measures
Name Time Method Hair count 6 monts follow up To verify hair removal and permanent hair reduction using the LightSheer Duet HS 805 nm handpiece
Number of subjects with Adverse Events 1 year To evaluate the safety of hair removal using the LightSheer Duet HS 805 nm handpiece
- Secondary Outcome Measures
Name Time Method Subject's comfort using VAS Baseline, 4, 8, 12, 16 weeks; To evaluate subject's assessment of comfort associated with treatments
Asses subject's perception of improvement and satisfaction 8, 16 weeks following baseline; 3 and 6 monts follow up To evaluate subject's satisfaction with hair removal treatments and assessment of improvement using subject's questionnaire
Trial Locations
- Locations (1)
Laser & Skin Surgery Medical Group Inc
🇺🇸Sacramento, California, United States